Prelude Therapeutics Inc — Director's Dealing 2021

Jul 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Prelude Therapeutics Inc (PRLD)
CIK: 0001678660
Period of Report: 2021-07-19

Reporting Person: Babler Martin (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-19	Employee Stock Option (Right to Buy)	$31.37	A	36400	Acquired	2031-07-18	Common Stock (36400)	Direct

Footnotes

F1: The stock option vested as to 1/36 of the total shares monthly beginning on August 19, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.